Analyst Price Targets — PODD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 13, 2026 1:46 pm | — | Truist Financial | $210.00 | $162.79 | TheFly | Insulet price target lowered to $210 from $219 at Truist |
| July 13, 2026 1:17 pm | — | RBC Capital | $245.00 | $163.11 | TheFly | Insulet price target lowered to $245 from $280 at RBC Capital |
| July 10, 2026 11:28 am | — | Stifel Nicolaus | $225.00 | $158.29 | StreetInsider | Insulet Corporation (PODD) PT Lowered to $225 at Stifel as Guidance Raise ExpectedMember Login |
| July 6, 2026 12:46 pm | — | Evercore ISI | $180.00 | $155.44 | TheFly | Insulet price target lowered to $180 from $200 at Evercore ISI |
| June 23, 2026 11:41 am | — | Deutsche Bank | $190.00 | $138.97 | TheFly | Insulet initiated with a Buy at Deutsche Bank |
| June 11, 2026 5:30 pm | — | UBS | $219.00 | $149.73 | TheFly | Insulet price target lowered to $219 from $250 at Truist |
| June 11, 2026 5:21 pm | Richard Newitter | Truist Financial | $219.00 | $149.19 | StreetInsider | Insulet Corporation (PODD) PT Lowered to $219 at Truist Securities |
| June 8, 2026 7:21 pm | — | Raymond James | $216.00 | $151.51 | TheFly | Insulet price target lowered to $216 from $263 at Raymond James |
| May 27, 2026 11:26 am | David Roman | Goldman Sachs | $205.00 | $153.80 | TheFly | Insulet price target lowered to $205 from $237 at Goldman Sachs |
| May 26, 2026 11:09 pm | — | BTIG | $235.00 | $153.80 | TheFly | Insulet price target lowered to $235 from $260 at BTIG |
Latest News for PODD
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive (the “Class Period”), of the important August 31, 2026 lead plaintiff deadline.
LOS ANGELES, July 17, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 31, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026, inclusive (the “Class Period”).
San Diego, California--(Newsfile Corp. - July 17, 2026) - Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026. Insulet develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the U.S. and internationally.
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Insulet Corporation (NASDAQ: PODD).
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.